Skip to content

McKesson MCK Q2 2025 earnings

Reported November 6, 2024 · After market close

Revenue estimate$89.3B
EPS estimate$6.88

Next report

Aug 5, 2026 (in a month)
Revenue estimate$104.00B
EPS estimate$9.63

Financials

Q2 2025

Income statement

See full
Revenue$93.7B+21.3%
Gross profit$3.2B+5.8%
Operating income$578.0M-39.2%
Net income$241.0M-63.7%
EPS (diluted)$1.87-62.0%

Balance sheet

See full
Cash & equivalents$2.5B-0.5%
Total debt$7.2B-2.1%
Total equity-$3.0B-65.0%
Total assets$72.4B+9.6%

Cash flow

See full
Operating cash flow$2.1B+118%
CapEx$136.0M+81.3%
Free cash flow$2.0B

Valuation & ratios

Q2 2025

Valuation

See full
Market cap$64.18B+10.1%
Enterprise value$68.89B+9.1%
P/E25.3×+8.6×
P/S0.2×0.0×

Profitability

See full
Gross margin4%-0.3pp
Operating margin1%-0.4pp
Net margin0.8%-0.4pp

Returns & leverage

See full
Current ratio0.9×0.0×

Segments

By segment

See full
Medical-Surgical Solutions$2.9B+4.0%
Prescription Technology Solutions$1.3B+11.0%

Versus estimates

Ask the moment McKesson reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did McKesson report Q2 2025 earnings?
McKesson (MCK) reported Q2 2025 earnings on November 6, 2024 after market close.
What were McKesson's Q2 2025 revenue and EPS?
McKesson reported revenue of $93.7B and diluted EPS of $7.07 for Q2 2025.
Did McKesson beat estimates in Q2 2025?
Revenue beat the consensus estimate of $89.3B by $4.3B. EPS beat the consensus estimate of $6.88 by $0.19.
Where can I find McKesson's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000927653-24-000125) directly on SEC EDGAR. The filing index links above go to sec.gov.